Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fudan University
T-ACE Medical Co., Ltd
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Research UK
University of Chicago
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Center Eugene Marquis
NYU Langone Health
Dana-Farber Cancer Institute
University of Florida
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University Hospital, Grenoble
Roswell Park Cancer Institute
Gruppo Oncologico del Nord-Ovest
University of Pittsburgh
University of Minnesota
Rutgers, The State University of New Jersey
Thomas Jefferson University
Case Comprehensive Cancer Center
Mirror Biologics, Inc.
Northwestern University
Children's Hospital Medical Center, Cincinnati
AIM ImmunoTech Inc.
Ability Pharmaceuticals SL
Metabiomics Corp
University Hospital, Bordeaux
ProgenaBiome
Weill Medical College of Cornell University
NextPoint Therapeutics, Inc.
Fudan University
Primocure Pharma
Coordinación de Investigación en Salud, Mexico
UNICANCER
Tehran University of Medical Sciences
Xijing Hospital of Digestive Diseases
Ohio State University Comprehensive Cancer Center
UMC Utrecht
The Clatterbridge Cancer Centre NHS Foundation Trust
Adlai Nortye Biopharma Co., Ltd.
St. Louis University
Oslo University Hospital
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Zhejiang Cancer Hospital
Universita di Verona
DNAtrix, Inc.
Obafemi Awolowo University Teaching Hospital